Margaret Hamburg: One of the Best Commissioners in FDA History

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.


You may also like

12 VCs Who Matter, But You Never Read About
Raiding the Talent at Pfizer: Where Might The R&D Brains Go?
The McKinsey Alumni: Where Are They Wielding Influence?
‘Pharmaphobia’ Pushes Back Against Anti-Industry Crusade, But Comes Up Short